Acerus Pharmaceuticals Corp. | Balance Sheet
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
19,268.10
35,925.40
8,797.20
6,972.10
3,954.30
5,229.60
Total Accounts Receivable
-
2,093.00
2,692.10
6,985.50
2,307.90
1,520.10
Inventories
2,033.40
5,551.50
5,256.40
5,271.70
3,926.70
3,585.20
Other Current Assets
1,681.90
231.70
197.30
87.20
92.70
77.90
Total Current Assets
22,983.30
43,801.50
16,942.90
19,316.50
10,281.70
10,412.90
Net Property, Plant & Equipment
3,477.80
2,247.00
2,869.90
2,293.20
1,863.10
1,730.50
Intangible Assets
3,417.90
41,913.60
20,851.80
18,241.00
15,738.30
10,834.90
Total Assets
29,878.90
87,962.10
41,081.20
39,850.60
27,883.10
22,978.20
ST Debt & Current Portion LT Debt
3,011.80
-
3,633.90
5,487.60
1,285.50
Accounts Payable
7,509.90
836.30
1,587.70
3,152.80
1,587.50
Other Current Liabilities
2,970.70
12,968.90
31,056.10
2,714.30
3,913.00
Total Current Liabilities
13,492.40
13,805.20
36,277.70
11,354.70
6,786.00
Long-Term Debt
1,941.30
27,531.60
7,522.00
3,160.90
4,439.20
Deferred Taxes
-
-
416.70
-
-
Other Liabilities
22.30
27,559.40
697.30
8,973.00
9,245.50
Total Liabilities
15,456.00
68,896.20
44,497.00
23,488.50
20,470.70
Common Equity (Total)
14,423.00
19,066.00
3,415.80
16,362.20
7,412.50
Total Shareholders' Equity
14,423.00
19,066.00
3,415.80
16,362.20
7,412.50
Total Equity
14,423.00
19,066.00
3,415.80
16,362.20
7,412.50
Liabilities & Shareholders' Equity
29,878.90
87,962.10
41,081.20
39,850.60
27,883.10
About Acerus Pharmaceuticals
View Profile
